Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Carmell Therapeutics (CTCX)
NASDAQ:CTCX
Holding CTCX?
Track your performance easily
CTCX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.20 - $4.31
Previous Close$0.25
Volume55.55K
Average Volume (3M)4.76M
Market Cap
$5.18M
Enterprise Value$4.85M
Total Cash (Recent Filing)$1.14M
Total Debt (Recent Filing)$781.70K
Price to Earnings (P/E)―
Beta1.42
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.56
Shares Outstanding20,905,407
10 Day Avg. Volume674,891
30 Day Avg. Volume4,761,446
Standard Deviation0.21
R-Squared0.00573
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)-1.29
Price to Sales (P/S)11.81
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.29
Enterprise Value/Gross Profit-1.12
Enterprise Value/Ebitda-0.28
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Carmell Therapeutics News
PremiumCompany Announcements
Carmell Therapeutics Unveils Innovative Skincare Breakthroughs
PremiumCompany Announcements
Carmell Therapeutics Announces CEO Transition and New Leadership Incentives
Ownership Overview
23.61% Insiders
1.24% Mutual Funds
10.92% Other Institutional Investors
63.23% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
CTCX FAQ
What was Carmell Therapeutics’s price range in the past 12 months?
Carmell Therapeutics lowest stock price was $0.20 and its highest was $4.31 in the past 12 months.
What is Carmell Therapeutics’s market cap?
Currently, no data Available
When is Carmell Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Carmell Therapeutics’s earnings last quarter?
Currently, no data Available
Is Carmell Therapeutics overvalued?
According to Wall Street analysts Carmell Therapeutics’s price is currently Overvalued.
Does Carmell Therapeutics pay dividends?
Carmell Therapeutics does not currently pay dividends.
What is Carmell Therapeutics’s EPS estimate?
Carmell Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Carmell Therapeutics have?
Carmell Therapeutics has 20,905,407 shares outstanding.
What happened to Carmell Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Carmell Therapeutics?
Among the largest hedge funds holding Carmell Therapeutics’s share is Saba Capital Management. It holds Carmell Therapeutics’s shares valued at N/A.
---
Carmell Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
CTCX Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 911.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $26.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-90.92%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-96.86%
Trailing 12-Months
Company Description
Carmell Therapeutics
Alpha Healthcare Acquisition Corp III is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
---
Technical Analysis
---